No Evidence of Increased Physical Activity-Related Hypoglycemia with Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes-ONWARDS 1-5

被引：0
|
作者：
Riddell, Michael C.
Heller, Simon R.
Asong, Marisse
Carstensen, Lisbeth
Watt, Sara K.
Woo, Vincent C.
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-830-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
830-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] CGM Outcomes and Hypoglycemia Duration with Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 in Insulin-Naive T2D-ONWARDS 1 Exploratory Analysis
    Bergenstal, Richard M.
    Watt, Sara K.
    Matos, Ana Laura S. A.
    Lingvay, Ildiko
    Mader, Julia K.
    Nishida, Tomoyuki
    Rosenstock, Julio
    DIABETES, 2023, 72
  • [32] Hypoglycemia Frequency and Physiological Response to Double or Triple Doses of Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine in T2D
    Svehlikova, Eva
    Arfelt, Kristine Niss
    Cailleteau, Roman
    Deller, Sigrid
    Thomsen, Karen Margrete
    Hart, Marlies
    Mursic, Ines
    Pieber, Thomas
    Haahr, Hanne
    DIABETES, 2022, 71
  • [33] CGM in insulin-experienced individuals with type 2 diabetes switched to once-weekly insulin icodec versus once-daily comparators in ONWARDS 2 and 4: post hoc analysis
    Asbjornsdottir, B.
    Bajaj, H. S.
    Lehrskov, L. L.
    Mathieu, C.
    Philis-Tsimikas, A.
    Wang, N.
    Battelino, T.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S398 - S398
  • [34] Improved treatment satisfaction with once-weekly insulin icodec compared with once-daily basal insulin in individuals with type 2 diabetes: An analysis of patient-reported outcomes and participant interviews from ONWARDS 2 and 5 and a physician survey from ONWARDS 1
    Polonsky, William
    Benamar, Malik
    Carstensen, Lisbeth
    Davies, Melanie
    Donatsky, Anders Meller
    Franek, Edward
    Kellerer, Monika
    Philis-Tsimikas, Athena
    Goldenberg, Ronald
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 217
  • [35] Cost-utility analysis and drug pricing of once-weekly insulin icodec versus once-daily insulin degludec for type 2 diabetes patients treated with basal insulin in China
    Hu, Shanshan
    Wang, Shuowen
    Gu, Shengying
    Qi, Chendong
    Shi, Chenyang
    Fan, Guorong
    DIABETES OBESITY & METABOLISM, 2024,
  • [36] Cost-utility analysis of once-weekly insulin icodec and once-daily insulin glargine in patients with type 2 diabetes receiving basal-bolus insulin therapy in China
    Dai, Nan
    Su, Xiaorong
    Wang, Yong
    DIABETES OBESITY & METABOLISM, 2025, 27 (01): : 377 - 386
  • [37] CGM outcomes and hypoglycaemia duration with once-weekly insulin icodec versus once-daily insulin glargine u100 in insulin-naive type 2 diabetes: ONWARDS 1 exploratory analysis
    Bergenstal, R.
    Watt, S. Kehlet
    Matos, A. S. A.
    Lingvay, I.
    Mader, J. K.
    Nishida, T.
    Rosenstock, J.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S397 - S397
  • [38] CGM-based parameters for once-weekly insulin icodec vs once-daily insulin glargine U100 in insulin-naive patients with type 2 diabetes
    Lingvay, I.
    Bang, R. Beck
    Liu, L.
    Mader, J.
    Pettus, J.
    Wagner, L.
    Mathieu, C.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 265 - 266
  • [39] Once-weekly basal insulin icodec offers comparable efficacy and safety vs once-daily insulin glargine U100 in insulin naive patients with type 2 diabetes inadequately controlled on OADs
    Rosenstock, J.
    Kjaersgaard, M.
    Moller, D.
    Hansen, M.
    Goldenberg, R.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S28 - S29
  • [40] Hypoglycaemia frequency and physiological response to double or triple doses of once-weekly insulin icodec versus once-daily insulin glargine in type 2 diabetes
    Pieber, T. R.
    Arfelt, K. N.
    Cailleteau, R.
    Thomsen, K. M. Due
    Hart, M.
    Mursic, I.
    Svehlikova, E.
    Urschitz, M.
    Haahr, H.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S333 - S333
12345